2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of PD-1 Inhibitor in AIDS-associated PML Pembrolizumab - Progressive Multifocal Leukoencephalopathy, AIDS | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 10 | 2019-08-20 | 2019-09-20 |
| Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein Tat Oyi - AIDS | Phase 1 / Phase 2 | Unknown | BIOSANTECH | 50 | 2013-02-01 | 2016-02-10 |
Acquired Immunodeficiency Syndrome (2) · Leukoencephalopathy, Progressive Multifocal (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · HIV Infections (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · Lentivirus Infections (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Slow Virus Diseases (2) · Urogenital Diseases (2) · Virus Diseases (2)
Immune Checkpoint Inhibitors (1) · pembrolizumab (1)
BIOSANTECH (1) · First Affiliated Hospital of Zhejiang University (1)
China (1) · France (1)
Biao Zhu, PhD (1) · Isabelle Ravaux, MD (1)